Adaptimmune Therapeutics plc Financial Flexibility Index
Adaptimmune Therapeutics plc financial flexibility index. Adaptimmune Therapeutics plc (473A) has a Financial Flexibility Index of -0.17x as of June 2025. Free cash flow of €-34.70 Million (operating CF €-34.78 Million minus capex €75.00K) represents 0% of total liabilities (€201.59 Million). See cash generation quality of Adaptimmune Therapeutics plc to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Adaptimmune Therapeutics plc (2016–2024)
Financial flexibility index of Adaptimmune Therapeutics plc from 2016 to 2024. Historical Financial Flexibility Index trend for Adaptimmune Therapeutics plc across 9 annual periods. Check how high is Adaptimmune Therapeutics plc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Adaptimmune Therapeutics plc Financial Flexibility Index by Year (2016–2024)
Adaptimmune Therapeutics plc financial flexibility index by year from 2016 to 2024. Year-by-year free cash flow to debt coverage for Adaptimmune Therapeutics plc. For the full cash flow conversion analysis, see Adaptimmune Therapeutics plc (473A) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.30x | €-70.49 Million | €-73.21 Million | €234.11 Million | ▲ +46.2% |
| 2023 | -0.56x | €-136.00 Million | €-140.88 Million | €243.10 Million | ▼ -23.1% |
| 2022 | -0.45x | €-112.27 Million | €-141.77 Million | €247.04 Million | ▼ -720.6% |
| 2021 | 0.07x | €19.30 Million | €10.73 Million | €263.58 Million | ▲ +115.7% |
| 2020 | -0.47x | €-51.25 Million | €-53.59 Million | €109.92 Million | ▲ +75.7% |
| 2019 | -1.92x | €-110.92 Million | €-112.51 Million | €57.91 Million | ▲ +43.1% |
| 2018 | -3.37x | €-100.48 Million | €-104.39 Million | €29.85 Million | ▼ -786.7% |
| 2017 | -0.38x | €-29.67 Million | €-54.31 Million | €78.16 Million | ▲ +26.6% |
| 2016 | -0.52x | €-35.38 Million | €-48.17 Million | €68.37 Million | — |